GlassScriptPhysician profile
Arvind Umesh Gowda
NPI 1972965820
$4,221.97
in general payments reported to CMS, 2019-2025
13 companies · $507 in 2025
The $507 reported for 2025 was more than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $579 · 2023: $2,182 · 2024: $953 · 2025: $507.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,544 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,544.15 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,770.66 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Axogen | $510.88 | 2023-2025 | Avance Nerve Graft |
| Depuy Synthes Sales INC. | $480.98 | 2022-2025 | Trumatch, Na, Matrixorthognathic |
| Kerecis Limited | $233.69 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Baxter Healthcare | $225.55 | 2024-2025 | |
| Abbvie INC. | $215.60 | 2024 | |
| Kls-Martin L.P. | $209.86 | 2022-2023 | |
| Mentor Worldwide LLC | $187.50 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Aroa Biosurgery Incorporated | $174.24 | 2024 | |
| Polynovo North America LLC | $141.17 | 2024 | Novosorb Btm |
| Allergan, INC. | $42.22 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $14.98 | 2024 | |
| Bioventus LLC | $14.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arvind Gowda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.